Dr. Pierre Lemieux is the Co-Founder, COO & Chief Scientific Officer at Acasti Pharma Inc.
As the Co-Founder a COO & Chief Scientific Officer of Acasti Pharma Inc, the total compensation of Dr Lemieux at Acasti Pharma Inc is $344,146. There are 3 executives at Acasti Pharma Inc getting paid more, with Janelle D' Alvise having the highest compensation of $565,484.
Dr Lemieux is 55, he's been the Co-Founder a COO & Chief Scientific Officer of Acasti Pharma Inc since . There are 7 older and no younger executives at Acasti Pharma Inc. The oldest executive at Acasti Pharma Inc is Janelle D'Alvise, 66, who is the Pres, CEO, Corp. Sec. & Director.
Pierre's mailing address filed with the SEC is C/O ACASTI PHARMA INC., 3009 BOUL. DE LA CONCORDE, SUITE 102, LAVAL, A6, H7E 2B5.
Over the last 3 years, insiders at Acasti Pharma Inc have traded over $0 worth of Acasti Pharma Inc stock and bought 676,752 units worth $1,252,067 . The most active insiders traders include Vimal Kavuru, John Canan a R. Loch Macdonald. On average, Acasti Pharma Inc executives and independent directors trade stock every 13 days with the average trade being worth of $785,032. The most recent stock trade was executed by Vimal Kavuru on 25 September 2023, trading 676,371 units of ACST stock currently worth $1,251,286.
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Acasti Pharma Inc executives and other stock owners filed with the SEC include: